Showing 11,021–11,040 of 17,974 drug recalls
Drug Recall
Terminated
Historical record Class II
FLUOCINONIDE 0.05% SOLUTION, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
FLUORORACIL 0.05% CREAM, FLUORORACIL 5% CREAM, FLUOROURACIL 4.9% IN CERAVE CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
ERYTHROMYCIN 2% IN CERAVE CREAM, ERYTHROMYCIN 3% / RETINOIC ACID 0.05%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
CLOBETASOL 0.05% IN OLEA BASE, CLOBETASOL 0.05% IN OROBASE, CLOBETASOL 0.05% OINTMENT, CLOBETASOL 0.05%/ SODIUM, SULFACETAMIDE 10% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
CLINDAMYCIN 1%, AZELAIC ACID 10% CREAM, CLINDAMYCIN 1.2%/ TRETINOIN 0.05% GEL, CLINDAMYCIN 1.2%/ TRETINOIN 0.1% GEL CLINDAMYCIN 2.5%, BENZOYL PEROXIDE 5%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
BLEACHING CREAM 0.1% CREAM, BLEACHING CREAM HQ4%, BLEACHING CREAM-NO HQ, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
BL 20%/4% CREAM, BLT 20%/6%/4% CREAM, BLT 20%/6%/6%, BLT 20% 8% 4% CREAM, BLT 20% 8% 4% OINTMENT, BLT 20% 8% 6% CREAM, BLT 20%/ 8% /8% OINTMENT, BLT 20%/ 8% /8% CREAM, BLT 20%/ 7%/ 7% CREAM, BLT 20%/ 10%/ 4% CREAM, BLT 20%/ 10%/ 10% CREAM, BLT 20%/ 20%/ 10% OINTMENT,BLT 7%/ 10%/ 7% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
BENZOYL PEROXIDE 5% CLINDAMYCIN 1.2%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
ADAPALENE 0.1%, BENZOYL PEROXIDE 2.5% GEL, ADAPELENE 0.3%, BENZOYL PEROXIDE 2,5% GEL, AZELAIC ACID 15% CREAM, AZELAIC ACID 20% IN OI FREE CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
BICARBONATE 10%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
MINOXADIL all strength including 2%, 5% and MINOXIDIL / RETINOIC ACID 5% / 0.025, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
5-FLUOROURACIL IN VANICREAM, FLUOROURACIL in all strengths including 0.05%, 5% CREAM, FLUOROURACIL 4.9% IN CERAVE CREAM, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
TACROLIMUS 0.1% Ointment and TACROLIMUS 0.1%/KETOCONAZOLE 2%, Rx only, Synergy Rx, 4901 Morena Blvd #504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
KETOCONAZOLE 2%/HYDROCORTISONE 1.5% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676. by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
HCG and HCG with resveratrol Human Chorionic Gonadotropin in different strengths: HCG 300 UNITS/RESVERATROL 50MG S.L. Tablet, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
CANTHARADIN 0.7% SOLUTION and CANTHARIDAN / PODOPHYLLUM SOLUTION, CANTHARIDIN/PODOPHYLLUM RESIN MIXTURE, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Human Chorionic Gonadotropin (HCG) 5,000 units/vial and 11,000 units/vial, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676 by Synergy Rx
Reason
Lack of Assurance of Sterility: There are also CGMP Deviations. Recall initiated
February 10, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class III
PreviDent 5000 ppm, DRY MOUTH, 1.1% Sodium Fluoride, PRESCRIPTION STRENGTH TOOTHPASTE, SLS Free Formula, SOOTHING MINT, 3.4 FL OZ (100 mL), Colgate Oral Pharmaceuticals, Inc., New York, NY 10022 --- NDC 0126-0016-61, UPC 3834110622 by Colgate Palmolive Co
Reason
Label Mix up; rear panel is incorrectly labeled with the PreviDent 5000 Enamel Protect rear panel. Recall initiated
February 13, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide
View recall →
Drug Recall
Terminated
Historical record Class II
GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21 by Amerisource Health Services
Reason
Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point. Recall initiated
February 3, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide
View recall →
Drug Recall
Terminated
Historical record Class III
Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles (NDC 0472-0987-91) and b) 60 mL applicator bottles (NDC 0472-0987-92), Rx Only, Manufactured by: G&W Laboratories, Inc., 111 Coolidge Street, South Plainfield, NJ 07080; Distributed by: Actavis Mid Atlantic LLC, 1877 Kawai Road, Lincolnton, NC 28092. by G & W Laboratories, Inc.
Reason
CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots. Recall initiated
February 28, 2017 Reported by FDA
March 22, 2017 Distribution
Nationwide in the USA.
View recall →
Data last updated: September 25, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .
